These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8103689)

  • 21. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
    Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
    J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry.
    Mattfeldt T; Kestler HA; Sinn HP
    Med Biol Eng Comput; 2004 Nov; 42(6):733-9. PubMed ID: 15587463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
    Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
    Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.
    Bader AA; Tio J; Petru E; Bühner M; Pfahlberg A; Volkholz H; Tulusan AH
    Breast Cancer Res Treat; 2002 Nov; 76(1):11-7. PubMed ID: 12408371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort study.
    Vieni S; Graceffa G; La Mendola R; Latteri S; Cordova A; Latteri MA; Cipolla C
    Int J Surg; 2016 Nov; 35():58-63. PubMed ID: 27633450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
    Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?
    Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH
    Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
    Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H
    Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.